Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more) Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Patience required...
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(91)
•••
Comment by jopatcloon Mar 21, 2024 8:26am
57 Views
Post# 35944491

RE:Patience required...

RE:Patience required...
chry200030 wrote: No quick money flippers here..
Buy and hold is the answer.
I love hearing about those hopefuls who think they can buy today and sell tomorrow and make $100,000..
It will come. If you have a heart, you will need VPT... 

good comment on Brazil

@cardinal 3.2 meets all requirments in Brazil--just whether they will focus there right now. They are very very busy in Europe and North america. In fact, I am pretty sure they are slowing conferences and just dealing with selling to current leads
@Anima Brazil can come later. They are correct to focus their resources on USA and UK.
 
1
 
@cardinal George likely headed back to Brazil at some point not too far off. The largest clinic in Brazil is interested. They’re massive. So is the USA though. Once we add the huge USA names, all others will gollow
@cardinal 3.2 meets all requirments in Brazil--just whether they will focus there right now. They are very very busy in Europe and North america. In fact, I am pretty sure they are slowing conferences and just dealing with selling to current leads
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities